Research has confirmed that the key targets of Galangin against liver cancer were SRC, ESR1, MMP9, CDK4, CCNB1, MMP2, CDK2, CDK1, CHEK1 and PLK1 (Li et al., 2024). The gene discussed is MMP2; the disease is liver cancer.